Mirae Asset Global Investments Co., Ltd. Cogent Biosciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,398 shares of COGT stock, worth $53,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,398
Previous 3,810
15.43%
Holding current value
$53,611
Previous $22,000
40.91%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding COGT
# of Institutions
195Shares Held
115MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$111 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$109 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$108 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$88.8 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$84.9 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $802M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...